___

• References Akarsu, S., Kurt, N. Ç., Kurt, A., Varol, İ. & Şen, Y. (2006). Değişik hastalık gruplarında trombosit hacim değişkenleri Orijinal Araştırma . Türk Pediatri Arşivi ,41 (4) , 208-213 .
• Bozan, N., Alpaycı, M., Aslan, M., Cankaya ,H., Kıroglu, A.F., Turan, M., Ayral, A., Senkoy, E., & Ilter S.(2016) Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds. Eur Arch Otorhinolaryngol, 273(11),3663-3672.
• Budak, Y.U, Polat ,M., & Huysal, K.(2016). The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochem Med (Zagreb), 26(2),178-193.
• Çakır, S., Kafadar, M.T., Arslan, Ş.N., Türkan, A., Kara, B., & İnan A. (2016). Meme kanseri tanısı konmuş kadınlarda risk faktörlerinin güncel veriler ışığında gözden geçirilmesi, İstanbul Bilim Üniversitesi Florence Nightingale Tıp Dergisi, 2(3), 186-194.
• Fahad Ullah, M.(2019). Breast Cancer: Current Perspectives on the Disease Status. Adv Exp Med Biol. 1152,51-64.
• Fu, S., Yun, Z.Y., Cui, M.M., Meng, H., Qian, C., Liu, T., Liu, ZP., Wang ,R.T., & Yu, K.J.(2017). Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients. Oncotarget. 8(40),67829-67836.
• Grivennikov, S.I., & Greten, F.R., Karin M. (2010) Immunity, inflammation, and cancer. Cell, 140(6), 883–99
• Jindal, S., Gupta, S., Gupta, R., Kakkar, A., Singh, H.V., Gupta, K., & Singh S.(2011). Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology,16(2),86-89.
• Kaushansky, K.( 2015). Thrombopoiesis. Semin Hematol. 52(1),4-11.
• Koça, S., Çelik, L., Özbaş, S., Sak, S.D., Tükün, A., & Yalçın, B. (2011): Meme kanserinde risk faktörleri, riskin değerlendirilmesi ve prevansiyon: İstanbul 2010 Konsensus Raporu. Meme Sağlığı Dergisi/Journal of Breast Health, 7(2),47-67.
• Menter, D.G., Kopetz, S., Hawk, E., Sood, A.K., Loree, J.M., Gresele. P., & Honn, K.V. (2017).Platelet “first responders” in wound response, cancer,and metastasis. Cancer Metastasis Rev 36(2),199-213.
• Mezouar, S., Frere, C., Darbousset R., Mege, D., Crescence, L., Dignat-George F., Panicot-Dubois, L., & Dubois, C. (2016).Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. Thromb Res 139, 65-76.
• Ozmen, V.(2014). Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients). J Breast Health. 10(2),98-105.
• Paulus, J.M. (1981). Recent advances in the story of megakaryocyte physiology. Pathol Biol (Paris). 29: 133-5.
• Rojas, K., & Stuckey, A.(2016). Breast Cancer Epidemiology and Risk Factors. Clin Obstet Gynecol. 59(4),651-672.
• Sirois M.(2014). Laboratory Procedures for Veterinary Technicians. 6th edition, Elsevier Health Sciences, ABD.
• Sun, H., Yin, C.Q., Liu, Q., Wang, F., & Yuan, C.H.(2017). Clinical Significance of Routine Blood Test-Associated Inflammatory Index in Breast Cancer Patients. Med Sci Monit. 23,5090-5095.
• Vagdatli, E., Gounari, E., Lazaridou, E., Katsibourlia,E., Tsikopoulou, F., & Labrianou, I. ( 2010). Platelet distribution width: a simple , practical and specific marker of activation of coagulation. HIPPOKRATIA.14(1),28-32.
• Wu,Y., Antony, S., Meitzler, J.L.,& Doroshow, J,H. (2014). Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett. 345(2), 164–173.
• Xia, W., Chen, W., Tu, J., Ni, C., & Meng, K.(2018). Prognostic Value and Clinicopathologic Features of Platelet Distribution Width in Cancer: A Meta-Analysis. Med Sci Monit. 24,7130-7136.
• Yıldız, E. (2014). Meme Kanseri. Tuzlalı S., Güllüoğlu M., Çevikbaş U. (Çeviri Ed), Robbins Temel Patoloji. 9th ed. 723-739,